$ADTX
Aditxt, Inc. Stock $adtx

$adtx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000121390023030316 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$221.0K	$185.6K	$933.7K
YoY Change	2.92%	76.71%	789.0%
Cost Of Revenue	$185.7K	$170.2K	$766.8K
YoY Change	6.22%	118.22%	883.3%
Gross Profit	$35.24K	$15.43K	$166.9K
YoY Change	-11.58%	-42.96%	517.14%
Gross Profit Margin	15.95%	8.31%	17.88%
Selling, General & Admin	$3.785M	$5.134M	$1.849M
YoY Change	353.85%	-77.0%	-94.99%
% of Gross Profit	10740.19%	33274.34%	1107.89%
Research & Development	$484.8K	$3.081M	$7.268M
YoY Change	-59.19%	81.0%	44.13%
% of Gross Profit	1375.81%	19969.15%	4353.81%
Depreciation & Amortization	$109.9K	$159.0K	$429.0K
YoY Change	10.07%	22.51%	-9.92%
% of Gross Profit	311.87%	1030.72%	256.97%
Operating Expenses	$4.270M	$8.215M	$25.65M
YoY Change	111.18%	-65.8%	-38.88%
Operating Profit	-$4.234M	-$8.200M	-$25.48M
YoY Change	-26.63%	-65.82%	-39.24%
Interest Expense	-$1.448M	$16.88K	-$2.229M
YoY Change	1731.22%	-128.71%	15.15%
% of Operating Profit
Other Income/Expense, Net	-$1.448M	$0.00	$2.170M
YoY Change	1731.25%		-51.09%
Pretax Income	-$5.682M	-$8.183M	-$27.65M
YoY Change	-2.87%	-65.98%	-40.37%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$5.682M	-$8.183M	-$27.65M
YoY Change	-2.87%	-65.98%	-40.37%
Net Earnings / Revenue	-2571.3%	-4409.04%	-2961.28%
Basic Earnings Per Share	-$0.92		-$14.89
Diluted Earnings Per Share	-$0.93	-$1.96	-$14.89
COMMON SHARES
Basic Shares Outstanding	4.833M shares	4.161M shares	1.855M shares
Diluted Shares Outstanding	6.178M shares		1.855M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$95.95K	$2.769M	$2.769M
YoY Change	-88.07%	-64.83%	-64.83%
Cash & Equivalents	$95.95K	$2.769M
Short-Term Investments
Other Short-Term Assets	$654.0K	$496.9K	$496.9K
YoY Change	10.76%	7.99%	7.99%
Inventory	$1.018M	$950.1K	$950.1K
Prepaid Expenses	$654.0K	$496.9K
Receivables	$379.2K	$528.0K	$528.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.148M	$4.744M	$4.744M
YoY Change	-40.97%	-49.63%	-49.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.104M	$2.319M	$5.479M
YoY Change	-10.26%	2.27%	-13.91%
Goodwill
YoY Change
Intangibles		$107.0K
YoY Change
Long-Term Investments	$287.3K	$355.4K	$355.4K
YoY Change	-30.08%	-6.3%	-6.3%
Other Assets	$0.00		$50.00K
YoY Change	-100.0%		-82.73%
Total Long-Term Assets	$5.146M	$5.992M	$5.992M
YoY Change	-27.54%	-17.32%	-17.32%
TOTAL ASSETS
Total Short-Term Assets	$2.148M	$4.744M	$4.744M
Total Long-Term Assets	$5.146M	$5.992M	$5.992M
Total Assets	$7.294M	$10.74M	$10.74M
YoY Change	-32.09%	-35.58%	-35.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.398M	$1.959M	$1.959M
YoY Change	12.15%	24.31%	24.31%
Accrued Expenses	$1.103M	$1.087M	$1.087M
YoY Change	-2.46%	-5.11%	-5.11%
Deferred Revenue
YoY Change
Short-Term Debt	$2.916M	$0.00	$0.00
YoY Change	525.94%
Long-Term Debt Due	$147.8K	$410.0K	$410.0K
YoY Change	-66.28%	-41.47%	-41.47%
Total Short-Term Liabilities	$9.744M	$3.644M	$3.644M
YoY Change	38.39%	1.01%	1.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$1.419M	$1.885M	$1.885M
YoY Change	-39.29%	-31.84%	-31.84%
Total Long-Term Liabilities	$1.419M	$1.885M	$1.885M
YoY Change	-39.29%	-34.45%	-34.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.744M	$3.644M	$3.644M
Total Long-Term Liabilities	$1.419M	$1.885M	$1.885M
Total Liabilities	$11.16M	$5.529M	$5.529M
YoY Change	19.03%	-14.72%	-14.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$106.7M	-$95.04M
YoY Change	34.63%	41.11%
Common Stock	$6.764K	$4.307K
YoY Change	-87.81%	-90.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$201.6K	$201.6K
YoY Change	0.0%	0.0%
Treasury Stock Shares		2.017K shares
Shareholders Equity	-$3.869M	$5.206M	$5.206M
YoY Change
Total Liabilities & Shareholders Equity	$7.294M	$10.74M	$10.74M
YoY Change	-32.09%	-35.58%	-35.58%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$5.682M	-$8.183M	-$27.65M
YoY Change	-2.87%	-65.98%	-40.37%
Depreciation, Depletion And Amortization	$109.9K	$159.0K	$429.0K
YoY Change	10.07%	22.51%	-9.92%
Cash From Operating Activities	-$3.282M	-$6.720M	-$22.39M
YoY Change	23.64%	-22.68%	0.51%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$88.82K	$367.1K
YoY Change	-100.0%	-177.19%	-136.14%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$268.5K	$125.2K
YoY Change	-100.0%	-103.21%	-100.82%
Cash From Investing Activities	$0.00	$179.7K	-$241.9K
YoY Change	-100.0%	-102.12%	-98.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$17.23M
YoY Change			-48.7%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.075M	64.01K	$17.53M
YoY Change	107.96%	-99.67%	-51.24%
NET CHANGE
Cash From Operating Activities	-3.282M	-6.720M	-$22.39M
Cash From Investing Activities	0.000	179.7K	-$241.9K
Cash From Financing Activities	3.075M	64.01K	$17.53M
Net Change In Cash	-206.6K	-6.476M	-$5.103M
YoY Change	-84.25%	-369.55%	94.14%
FREE CASH FLOW
Cash From Operating Activities	-$3.282M	-$6.720M	-$22.39M
Capital Expenditures	$0.00	$88.82K	$367.1K
Free Cash Flow	-$3.282M	-$6.809M	-$22.76M
YoY Change	29.82%	-20.61%	7.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39336
CY2022	dei	Entity Registrant Name EntityRegistrantName	Aditxt, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3204328
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	737 N. Fifth Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Richmond
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	23219
CY2022	dei	City Area Code CityAreaCode	(650)
CY2022	dei	Local Phone Number LocalPhoneNumber	870-1200
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	ADTX
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	7923275	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4832714	shares
CY2022	dei	Auditor Firm AuditorFirmId	3501
CY2022	dei	Auditor Name AuditorName	dbbmckennon
CY2022	dei	Auditor Location AuditorLocation	San Diego, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2768640	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7872061	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-14.89
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	527961	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1854724	shares
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89844	usd
CY2022Q4	us-gaap	Public Utilities Inventory PublicUtilitiesInventory	950093	usd
CY2021Q4	us-gaap	Public Utilities Inventory PublicUtilitiesInventory	494697	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	496869	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	460102	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	500000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4743563	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9416704	usd
CY2022Q4	adtx	Fixed Asset FixedAsset	2318863	usd
CY2021Q4	adtx	Fixed Asset FixedAsset	2267297	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	107000	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	214000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	355366	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	379250	usd
CY2022Q4	adtx	Right Of Use Asset Long Term RightOfUseAssetLongTerm	3160457	usd
CY2021Q4	adtx	Right Of Use Asset Long Term RightOfUseAssetLongTerm	4097117	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	50000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	289539	usd
CY2022Q4	us-gaap	Assets Assets	10735249	usd
CY2021Q4	us-gaap	Assets Assets	16663907	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1958502	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1575543	usd
CY2022Q4	adtx	Financing On Fixed Assets FinancingOnFixedAssets	409983	usd
CY2021Q4	adtx	Financing On Fixed Assets FinancingOnFixedAssets	700433	usd
CY2022Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	188581	usd
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	186058	usd
CY2022Q4	adtx	Operating Lease Liability Short Term Current OperatingLeaseLiabilityShortTermCurrent	1086658	usd
CY2021Q4	adtx	Operating Lease Liability Short Term Current OperatingLeaseLiabilityShortTermCurrent	1145126	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3643724	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3607160	usd
CY2021Q4	adtx	Financing Of Fixed Asset Long Term FinancingOfFixedAssetLongTerm	110041	usd
CY2022Q4	adtx	Operating Lease Liability Long Term Noncurrent OperatingLeaseLiabilityLongTermNoncurrent	1885218	usd
CY2021Q4	adtx	Operating Lease Liability Long Term Noncurrent OperatingLeaseLiabilityLongTermNoncurrent	2765933	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5528942	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6483134	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4307487	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	890614	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	381811	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4305470	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	888579	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4307	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	899	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2017	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2017	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	201605	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	201605	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100443967	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	77734288	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95040362	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67352809	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5206307	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10180773	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10735249	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16663907	usd
CY2022	us-gaap	Revenues Revenues	933715	usd
CY2021	us-gaap	Revenues Revenues	105034	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	766779	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	77979	usd
CY2022	us-gaap	Gross Profit GrossProfit	166936	usd
CY2021	us-gaap	Gross Profit GrossProfit	27055	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15985552	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22084389	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7268084	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5042617	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1849460	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	334977	usd
CY2022	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	543938	usd
CY2021	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	14500000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	25647034	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	41961983	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-25480098	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-41934928	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	753038	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	93209	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	57348	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	3101	usd
CY2022	us-gaap	Other Income OtherIncome	58960	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2500970	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1533048	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1845358	usd
CY2022	us-gaap	Other Expenses OtherExpenses	2169778	usd
CY2021	us-gaap	Other Expenses OtherExpenses	4436436	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27649876	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46371364	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27649876	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-46371364	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	37667	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	102267	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27612199	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-46269097	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-14.89
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-121.18
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1854724	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	381811	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10180773	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	1413904	usd
CY2022	adtx	Issuance Of Restricted Stock Units For Compensation IssuanceOfRestrictedStockUnitsForCompensation	1209906	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	507558	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1203769	usd
CY2022	adtx	Sale Of Series B Preferred Shares To Related Party SaleOfSeriesBPreferredSharesToRelatedParty	20000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	-20000	usd
CY2022	adtx	Shares Issued As Inducement On Loans Net Of Issuance Costs SharesIssuedAsInducementOnLoansNetOfIssuanceCosts	146522	usd
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	878622	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	96030	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	17233307	usd
CY2022	adtx	Issuance Costs Related To Exercise Of Warrants Modification Of Warrants And Issuance Of Warrants IssuanceCostsRelatedToExerciseOfWarrantsModificationOfWarrantsAndIssuanceOfWarrants	-94195	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2022	adtx	Rounding Adjustment From Stock Split RoundingAdjustmentFromStockSplit	-13	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27649876	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11011482	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	1016962	usd
CY2021	adtx	Exercise Of Warrants ExerciseOfWarrants	3727285	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1843902	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	336117	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1443700	usd
CY2021	adtx	Issuance Of Shares For The Settlement Of Debt IssuanceOfSharesForTheSettlementOfDebt	5749922	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1322840	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	26123611	usd
CY2021	adtx	Issuance Of Shares For Offerings Net Of Issuance Costs IssuanceOfSharesForOfferingsNetOfIssuanceCosts	3745000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	231316	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-46371364	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10180773	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-27649876	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-46371364	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3131368	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4640681	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17530503	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35954670	usd
CY2022	us-gaap	Depreciation Depreciation	428977	usd
CY2021	us-gaap	Depreciation Depreciation	369236	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	107000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	107000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1533048	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1845358	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2500970	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-543938	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-14500000	usd
CY2022	adtx	Disposal Of Fixed Assets1 DisposalOfFixedAssets1	6976	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36767	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	312460	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-23884	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	306954	usd
CY2022	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	438117	usd
CY2021	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	89844	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	455396	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	494697	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	412959	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1333930	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22392006	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22278144	usd
CY2022	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	367079	usd
CY2021	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	1015752	usd
CY2022	adtx	Ti Allowance Receivable TIAllowanceReceivable	-125161	usd
CY2021	adtx	Ti Allowance Receivable TIAllowanceReceivable	287018	usd
CY2021	adtx	Note Receivables And Accrued Interest NoteReceivablesAndAccruedInterest	15002521	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-241918	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16305291	usd
CY2022	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	80000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	80000	usd
CY2022	adtx	Discount On Convertible Note Payable From Offering Costs DiscountOnConvertibleNotePayableFromOfferingCosts	2795000	usd
CY2021	adtx	Discount On Convertible Note Payable From Offering Costs DiscountOnConvertibleNotePayableFromOfferingCosts	4473540	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-3206887	usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-315790	usd
CY2022	adtx	Sale Of Preferred Shares To Related Party SaleOfPreferredSharesToRelatedParty	20000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-20000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17233307	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	29868611	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1109574	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3727285	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	400491	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	598976	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1200000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5206307	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5103421	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2628765	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7872061	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10500826	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2768640	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7872061	usd
CY2022	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	753038	usd
CY2021	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	15789	usd
CY2021	adtx	Original Offering Discount On Convertible Note Payable OriginalOfferingDiscountOnConvertibleNotePayable	5749922	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3131388	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	80000	usd
CY2021	adtx	Original Issuance Discount On Notes Payable OriginalIssuanceDiscountOnNotesPayable	1000000	usd
CY2022	adtx	Debt Discount From Warrants Issued With Convertible Note Payable DebtDiscountFromWarrantsIssuedWithConvertibleNotePayable	878622	usd
CY2021	adtx	Debt Discount From Warrants Issued With Convertible Note Payable DebtDiscountFromWarrantsIssuedWithConvertibleNotePayable	1322840	usd
CY2021	adtx	Debt Discount From Warrant Consideration For Convertible Debt Offering Costs DebtDiscountFromWarrantConsiderationForConvertibleDebtOfferingCosts	231316	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	146522	usd
CY2021	adtx	Liability Recognized For Financed Assets LiabilityRecognizedForFinancedAssets	821862	usd
CY2021	adtx	Reduction In Exercise Price Of Warrants ReductionInExercisePriceOfWarrants	102267	usd
CY2022	adtx	Shares Issued For Intangible Assets SharesIssuedForIntangibleAssets	96030	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	37677	usd
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	50000	usd
CY2021Q3	us-gaap	Common Unit Issued CommonUnitIssued	91667	shares
CY2021Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	120
CY2021Q3	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	11000000	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	91667	shares
CY2021Q3	adtx	Debt Instrument Term Description DebtInstrumentTermDescription	The warrants have an exercise price of $126.50 per share and are exercisable for a five-year period commencing six months from the date of issuance.
CY2021Q3	adtx	Warrants Exercise Price WarrantsExercisePrice	75
CY2021Q3	adtx	Purchase Of Common Stock PurchaseOfCommonStock	4584	shares
CY2021Q4	us-gaap	Common Unit Issued CommonUnitIssued	56667	shares
CY2021Q4	adtx	Exercise Price Per Shares ExercisePricePerShares	75
CY2021Q4	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	4250000	usd
CY2021Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	3910000	usd
CY2021Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	16000000	usd
CY2021Q4	us-gaap	Common Unit Issued CommonUnitIssued	164929	shares
CY2021Q4	adtx	Prefunded Warrants Shares PrefundedWarrantsShares	166572	shares
CY2021Q4	adtx	Exercise Price Per Shares ExercisePricePerShares	57.5
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	17200000	usd
CY2022Q3	adtx	Purchase Of Equity Shares PurchaseOfEquityShares	2109000	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	3333333	shares
CY2022Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	6
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.001
CY2021Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	1690420	usd
CY2020Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	19487	usd
CY2022	adtx	Net Loss Cash Flow From Operating Activities NetLossCashFlowFromOperatingActivities	27649876	usd
CY2022	us-gaap	Interest Paid InterestPaid	22049040	usd
CY2022Q4	us-gaap	Cash Cash	2768640	usd
CY2022Q4	us-gaap	Customer Funds CustomerFunds	51500000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates. Significant estimates underlying the financial statements include the collectability of notes receivable, collectability and reserve on accounts receivable, the reserve on insurance billing, and the fair value of stock options and warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentrations of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company may have deposits in excess of federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all the Company’s accounts receivable are with companies in the healthcare industry, individuals, and the U.S. government. However, concentration of credit risk is mitigated due to the Company’s number of customers. In addition, for receivables due from U.S government agencies, the Company does not believe the receivables represent a credit risk as these are related to healthcare programs funded by the U.S. government and payment is primarily dependent upon submitting the appropriate documentation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Restricted Stock Award Forfeitures Dividends RestrictedStockAwardForfeituresDividends	37667	usd
CY2021	us-gaap	Restricted Stock Award Forfeitures Dividends RestrictedStockAwardForfeituresDividends	102267	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	18634	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022	us-gaap	Depreciation Depreciation	428977	usd
CY2021	us-gaap	Depreciation Depreciation	369236	usd
CY2022Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	1359091	usd
CY2022	adtx	Licensing Fee For Patents LicensingFeeForPatents	263273	usd
CY2021	adtx	Licensing Fee For Patents LicensingFeeForPatents	76455	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7268084	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5042617	usd
CY2022	adtx	Warrants Of Stock Options WarrantsOfStockOptions	44710	shares
CY2022	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	7197	shares
CY2022	adtx	Dilutive Earning Shares DilutiveEarningShares	5090024	shares
CY2021	adtx	Warrants Of Stock Options WarrantsOfStockOptions	44710	shares
CY2021	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	15565	shares
CY2021	adtx	Warrants Exercised Shares WarrantsExercisedShares	601399	shares
CY2021Q3	us-gaap	Other Loans Payable OtherLoansPayable	6500000	usd
CY2021Q3	adtx	Common Stock Yields Percentage CommonStockYieldsPercentage	0.50	pure
CY2021Q4	adtx	Description Of Share Exchange Agreement DescriptionOfShareExchangeAgreement	On December 28, 2021, we entered into a Share Exchange Agreement with Cellvera Global f/k/a AiPharma Global, pursuant to which we (i) will acquire 9.5% of the issued and outstanding equity interests in Cellvera Global in exchange for the issuance of 96,324 shares of our common stock of Aditxt and a cash payment of $250,000, at an initial closing upon the satisfaction or waiver of certain conditions to closing; and (ii) acquire the remaining 90.5% of the issued and outstanding equity interests in Cellvera Global in exchange for the issuance of 798,560 shares of our common stock and a cash payment of $250,000 at a secondary closing upon the satisfaction or waiver of certain conditions to closing.
CY2021Q3	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	6500000	usd
CY2021Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2021Q4	adtx	Credit Agreement Amendment Description CreditAgreementAmendmentDescription	the Company entered into the first amendment to the Credit Agreement with Cellvera Global and certain affiliated entities (the “Credit Agreement Amendment”), pursuant to which the Company agreed to increase the amount which Cellvera Global was permitted to borrow under the Credit Agreement by $8.5 million to an aggregate of $15.0 million, of which $6.5 million was outstanding prior to entering the Credit Agreement Amendment. The Company agreed to fund such additional borrowings, as requested by Cellvera Global, by advancing 70% of any amounts received by the Company from the exercise of existing warrants or any other capital raises, including the October Offering.
CY2021	adtx	Advanced Credit Agreement AdvancedCreditAgreement	8000000	usd
CY2021	adtx	Credit Agreement CreditAgreement	14500000	usd
CY2021Q4	us-gaap	Loans Receivable With Variable Rates Of Interest1 LoansReceivableWithVariableRatesOfInterest1	14500000	usd
CY2022Q1	us-gaap	Securities Purchased Under Agreements To Resell Allowance For Credit Loss SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLoss	14500000	usd
CY2022Q2	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	30000000	usd
CY2021Q4	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	500000	usd
CY2021Q4	adtx	Debt Loan Amount DebtLoanAmount	4500000	usd
CY2021Q4	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	8	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	500000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3134850	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	815987	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2318863	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2654307	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	387010	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2267297	usd
CY2020Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2021Q1	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	9733	usd
CY2021Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2021Q1	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	37171	usd
CY2021Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	111512	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	111512	usd
CY2022	adtx	Amortization Of Intangible Asset AmortizationOfIntangibleAsset	107000	usd
CY2021	adtx	Amortization Of Intangible Asset AmortizationOfIntangibleAsset	107000	usd
CY2022	adtx	Estimated Useful Life EstimatedUsefulLife	P3Y
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.001
CY2022Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	20000	usd
CY2022Q3	adtx	Preferred Stock Votes PreferredStockVotes	250000000	shares
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	20000	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0475	pure
CY2022Q4	adtx	Promissory Notes PromissoryNotes	80000	usd
CY2022Q2	adtx	Gross Proceeds GrossProceeds	550000	usd
CY2022Q2	us-gaap	Legal Fees LegalFees	16500	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	13500	usd
CY2022Q4	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	28000	usd
CY2022Q3	adtx	Aggregate Amount AggregateAmount	288000	usd
CY2022Q3	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	200000	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	20000	usd
CY2022Q3	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	14400	usd
CY2022Q3	adtx	Principal Amount Percentage PrincipalAmountPercentage	0.10	pure
CY2022Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1150000	usd
CY2022Q3	adtx	Investor Purchase Amount InvestorPurchaseAmount	555556	usd
CY2022Q3	adtx	Gross Proceeds GrossProceeds	500000	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11112	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	47182	shares
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	11.78
CY2021Q3	adtx	Warrant Exercise Price WarrantExercisePrice	7.5
CY2022Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	6
CY2022Q3	adtx	Principal Amount PrincipalAmount	555555	usd
CY2022Q3	adtx	Gross Proceeds GrossProceeds	500000	usd
CY2022Q4	adtx	Exercise Price ExercisePrice	7.5
CY2022Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	6
CY2022Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2388888	usd
CY2022	us-gaap	Prepayment Fees On Advances Net PrepaymentFeesOnAdvancesNet	238889	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	119444	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1396875	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	819587	usd
CY2022	us-gaap	Lease Cost LeaseCost	1396875	usd
CY2021	us-gaap	Lease Cost LeaseCost	819587	usd
CY2022Q4	adtx	Right Of Use Asset Short Term RightOfUseAssetShortTerm	3160457	usd
CY2021Q4	adtx	Right Of Use Asset Short Term RightOfUseAssetShortTerm	4097117	usd
CY2022	adtx	Total Right Of Use Asset TotalRightOfUseAsset	3160457	usd
CY2021	adtx	Total Right Of Use Asset TotalRightOfUseAsset	4097117	usd
CY2022Q4	adtx	Operating Lease Liabilities Short Term OperatingLeaseLiabilitiesShortTerm	1086658	usd
CY2021Q4	adtx	Operating Lease Liabilities Short Term OperatingLeaseLiabilitiesShortTerm	1145126	usd
CY2022Q4	adtx	Operating Lease Liabilities Long Term OperatingLeaseLiabilitiesLongTerm	1885218	usd
CY2021Q4	adtx	Operating Lease Liabilities Long Term OperatingLeaseLiabilitiesLongTerm	2765933	usd
CY2022Q4	adtx	Total Lease Liability TotalLeaseLiability	2971876	usd
CY2021Q4	adtx	Total Lease Liability TotalLeaseLiability	3911059	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1129853	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1004982	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	710546	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	423930	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3269311	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	297436	usd
CY2022Q4	adtx	Operating Leases Liability Current OperatingLeasesLiabilityCurrent	1086657	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1885218	usd
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	500	shares
CY2020Q3	us-gaap	Taxes And Licenses TaxesAndLicenses	455000	usd
CY2022Q1	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	175000	usd
CY2022Q1	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	175000	usd
CY2022Q1	srt	Extensions Discoveries Additions And Improved Recovery Less Related Costs ExtensionsDiscoveriesAdditionsAndImprovedRecoveryLessRelatedCosts	100000	usd
CY2018	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	70000	usd
CY2018	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	60000	usd
CY2018	us-gaap	Product Liability Contingency Third Party Recovery Percentage ProductLiabilityContingencyThirdPartyRecoveryPercentage	0.0075	pure
CY2022Q1	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	100000	usd
CY2020Q1	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	25000	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	375	shares
CY2022	us-gaap	Sale Leaseback Transaction Other Payments Required SaleLeasebackTransactionOtherPaymentsRequired	25000	usd
CY2022	adtx	Payment Of Milestone Fees PaymentOfMilestoneFees	50000	usd
CY2022	us-gaap	Clearance Fees ClearanceFees	25000	usd
CY2022Q1	us-gaap	Registration Payment Arrangement Maximum Potential Consideration RegistrationPaymentArrangementMaximumPotentialConsideration	25000	usd
CY2020Q2	us-gaap	Financial Guarantee Insurance Contracts Accelerated Premium Revenue Amount FinancialGuaranteeInsuranceContractsAcceleratedPremiumRevenueAmount	10000000	usd
CY2022	us-gaap	Broadcasters License Agreement Commitments Description BroadcastersLicenseAgreementCommitmentsDescription	In addition to the annual license maintenance fees outlined above, we will pay Stanford royalties on Net Sales (as such term is defined in the February 2020 License Agreement) during the of the term of the agreement as follows: 4% when Net Sales are below or equal to $5 million annually or 6% when Net Sales are above $5 million annually.
CY2022	us-gaap	Loss Contingency Accrual Product Liability Net Explanation Of Material Change In Accrual LossContingencyAccrualProductLiabilityNetExplanationOfMaterialChangeInAccrual	$5
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	148227	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	507558	usd
CY2022Q4	adtx	Shares Issued1 SharesIssued1	58256	shares
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1224333	shares
CY2021	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	2031	shares
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	254242	usd
CY2021	adtx	Shares Of Common Stock SharesOfCommonStock	1602	shares
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	189843	shares
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3727285	usd
CY2021	adtx	Settlement Of Accounts Payable Shares SettlementOfAccountsPayableShares	500	shares
CY2021	adtx	Recognized Expense RecognizedExpense	1843902	usd
CY2021Q4	adtx	Shares Of Common Stock SharesOfCommonStock	96050	shares
CY2021Q4	adtx	Shares Issued1 sharesIssued1	91667	shares
CY2021Q4	adtx	Shares Of Common Stock SharesOfCommonStock	56667	shares
CY2021Q4	adtx	Shares Of Common Stock SharesOfCommonStock	164929	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q3	adtx	Shares Of Common Stock SharesOfCommonStock	1	shares
CY2019Q3	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	20000	usd
CY2019Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	250000000	shares
CY2022	us-gaap	Redemption Premium RedemptionPremium	20000	usd
CY2022Q4	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	20000	usd
CY2022Q4	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	1	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	60000	shares
CY2021Q1	adtx	Fair Market Value FairMarketValue	1	pure
CY2021	adtx	Company Granted CompanyGranted	1850	shares
CY2021	adtx	Weighted Average Grant weightedAverageGrant	8.39	usd
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	42685	shares
CY2022	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	173.5
CY2020	adtx	Stock Options Shares StockOptionsShares	791187	shares
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	826795	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	587209	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	239586	usd
CY2022Q4	adtx	Warrant Issued warrantIssued	6497530	shares
CY2021Q4	adtx	Warrant Issued warrantIssued	678242	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	200
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	adtx	Warrants Issued And Vesting WarrantsIssuedAndVesting	609748	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	105049	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	504699	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P0Y2M19D
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	179419	usd
CY2022Q2	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	57.5
CY2022Q2	adtx	Gross Proceeds GrossProceeds	1350000	usd
CY2022Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	407991	shares
CY2022Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	12.395	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3759044	usd
CY2022Q4	adtx	Offering Reflecting Reduced Exercise Price Per Share OfferingReflectingReducedExercisePricePerShare	12.395
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	96
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	22.74
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	70.65
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	77.5
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.72
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	18506	shares
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.016	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.069	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.01	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.001	pure
CY2022	adtx	Permanent Differences Others PermanentDifferencesOthers	-0.105	pure
CY2021	adtx	Permanent Differences Others PermanentDifferencesOthers	-0.05	pure
CY2022	adtx	Change In Valuation Allowancein Dollars ChangeInValuationAllowanceinDollars	-0.131	pure
CY2021	adtx	Change In Valuation Allowancein Dollars ChangeInValuationAllowanceinDollars	-0.23	pure
CY2022	adtx	Total Provision For Income Taxesin Dollars TotalProvisionForIncomeTaxesinDollars	0	pure
CY2021	adtx	Total Provision For Income Taxesin Dollars TotalProvisionForIncomeTaxesinDollars	0	pure
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	13499811	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	10896410	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	430468	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	161943	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1511849	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1541936	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	722126	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	1169887	usd
CY2022	adtx	Section174 Capitalization Section174Capitalization	1547343	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3288363	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4140318	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	114973	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	23933	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21114933	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17934427	usd
CY2022	adtx	Valuation Allowance ValuationAllowance	-20217401	usd
CY2021	adtx	Valuation Allowance ValuationAllowance	-16670590	usd
CY2022	adtx	Net Deferred Tax Assets NetDeferredTaxAssets	897533	usd
CY2021	adtx	Net Deferred Tax Assets NetDeferredTaxAssets	1263837	usd
CY2022	adtx	Right Of Use Assets RightOfUseAssets	-722127	usd
CY2021	adtx	Right Of Use Assets RightOfUseAssets	-1169887	usd
CY2022	adtx	Fixed Assets FixedAssets	-175406	usd
CY2021	adtx	Fixed Assets FixedAssets	-93950	usd
CY2022	adtx	Total Deferred Tax Liabilities TotalDeferredTaxLiabilities	-897533	usd
CY2021	adtx	Total Deferred Tax Liabilities TotalDeferredTaxLiabilities	-1263837	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3500000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	56600000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	38000000	usd
CY2022	adtx	Net Operating Loss Carryover NetOperatingLossCarryover	1	pure
CY2022	adtx	Income Loss Of Generated incomeLossOfGenerated	P20Y
CY2021	adtx	Net Operating Losse NetOperatingLosse	56500000	usd
CY2021	adtx	Net Operating Losses Generated Prior NetOperatingLossesGeneratedPrior	100000	usd
CY2021	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	The CARES Act temporarily allows the Company to carryback net operating losses arising in 2018, 2019 and 2020 to the five prior tax years.
CY2017Q4	adtx	Percentage Of Income Taxable PercentageOfIncomeTaxable	0.80	pure
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	26200000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	44800000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	100000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	400000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	200000	usd
CY2022Q4	adtx	Aggregate Offering Pricea Amount AggregateOfferingPriceaAmount	50000000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	adtx	Financing Of Fixed Asset Long Term FinancingOfFixedAssetLongTerm		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-121.18
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	adtx	Disposal Of Fixed Assets1 DisposalOfFixedAssets1		usd
CY2022	adtx	Note Receivables And Accrued Interest NoteReceivablesAndAccruedInterest		usd
CY2021	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable		usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2021	adtx	Sale Of Preferred Shares To Related Party SaleOfPreferredSharesToRelatedParty		usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	adtx	Original Offering Discount On Convertible Note Payable OriginalOfferingDiscountOnConvertibleNotePayable		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	adtx	Original Issuance Discount On Notes Payable OriginalIssuanceDiscountOnNotesPayable		usd
CY2022	adtx	Debt Discount From Warrant Consideration For Convertible Debt Offering Costs DebtDiscountFromWarrantConsiderationForConvertibleDebtOfferingCosts		usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2022	adtx	Liability Recognized For Financed Assets LiabilityRecognizedForFinancedAssets		usd
CY2022	adtx	Reduction In Exercise Price Of Warrants ReductionInExercisePriceOfWarrants		usd
CY2021	adtx	Shares Issued For Intangible Assets SharesIssuedForIntangibleAssets		usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive		usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2021	adtx	Section174 Capitalization Section174Capitalization		usd
CY2022	adtx	Net Deferred Taxes NetDeferredTaxes		usd
CY2021	adtx	Net Deferred Taxes NetDeferredTaxes		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001726711

Files In Submission

Name	View Source	Status
0001213900-23-030316-index-headers.html	Edgar Link	pending
0001213900-23-030316-index.html	Edgar Link	pending
0001213900-23-030316.txt	Edgar Link	pending
0001213900-23-030316-xbrl.zip	Edgar Link	pending
adtx-20221231.xsd	Edgar Link	pending
f10k2022ex23-1_aditxtinc.htm	Edgar Link	pending
f10k2022ex31-1_aditxtinc.htm	Edgar Link	pending
f10k2022ex31-2_aditxtinc.htm	Edgar Link	pending
f10k2022ex32-1_aditxtinc.htm	Edgar Link	pending
f10k2022_aditxtinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
adtx-20221231_cal.xml	Edgar Link	unprocessable
adtx-20221231_def.xml	Edgar Link	unprocessable
adtx-20221231_pre.xml	Edgar Link	unprocessable
adtx-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_aditxtinc_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ADTX
Aditxt, Inc. Stock $adtx

2023 Q2 Form 10-K Financial Statement

#000121390023030316 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADTX Aditxt, Inc. Stock $adtx

2023 Q2 Form 10-K Financial Statement

#000121390023030316 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADTX
Aditxt, Inc. Stock $adtx